Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Groups / Prostate and Urologic Cancers Research Group / Completed validation of %[-2]proPSA to improve PSA-based detection of prostate cancer; IVD FDA approved

Completed validation of %[-2]proPSA to improve PSA-based detection of prostate cancer; IVD FDA approved

Click here to view more information in the biomarker database for proPSA

EDRN Orientation Meeting 2016
The In-person EDRN Orientation Meeting will take place Wednesday, October 19-Friday, October 21, 2016 in Bethesda, MD. More information such as meeting registration and hotel reservations will be sent to new/continuing EDRN members soon.
Announcement